FDA Approves Aimovig(TM) (erenumab-aooe), A Novel Treatment Developed Specifically For Migraine Prevention

Migraine is a Severe Neurologic Disease That Profoundly Impacts Millions of Patients in the United States Aimovig is the First and Only FDA-Approved Treatment to Block the Calcitonin Gene-Related Peptide Receptor (CGRP-R), Which Plays an Important Role ... Biopharmaceuticals, Devices, Drug Delivery, FDA Amgen, Aimovig, erenumab, migraine, SureClick, autoinjector
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news